North America Tracheostomy Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Tracheostomy Tubes, Tracheostomy Ventilation Accessories, Tracheostomy Clean and Care Kits, and Other Acces
Description
The North American tracheostomy market was valued at approximately USD 369.38 million in 2023 and is projected to grow to USD 603.40 million by 2031, reflecting a compound annual growth rate (CAGR) of 6.3% during the forecast period from 2023 to 2031. This growth is significantly driven by the increasing geriatric population, which is more susceptible to respiratory diseases and conditions that necessitate tracheostomy procedures.
As individuals age, they often experience a decline in lung function and an increased risk of respiratory ailments such as chronic obstructive pulmonary disease (COPD), pneumonia, and asthma. The global trend shows a rising geriatric demographic, which is expected to further fuel the demand for tracheostomy interventions. For instance, the U.S. Census Bureau projects that the number of Americans aged 65 and older will increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. This age group is anticipated to grow from 17% to 23% of the total U.S. population by 2050. Similarly, Statistics Canada reported that in 2022, approximately 18.8% of Canadians, or about 7.3 million people, were aged 65 or older. The World Health Organization (WHO) also highlights that by 2030, one in six people globally will be aged 60 or older, with the number expected to reach 1.4 billion by 2030 and 2.1 billion by 2050. Notably, by 2050, 80% of older individuals will reside in low- and middle-income countries. This demographic shift is a key driver for the growth of the tracheostomy market in North America.
A tracheostomy is a surgical procedure that involves creating an opening in the front of the neck to access the trachea directly. This procedure is commonly performed in cases of airway obstruction, respiratory failure, trauma, or when prolonged mechanical ventilation is required. According to a 2020 article in Critical Care Medicine, around 100,000 tracheostomies are performed annually in the United States alone.
The North American tracheostomy market is also influenced by government initiatives aimed at addressing product shortages. For example, in October 2022, the U.S. Food and Drug Administration (FDA) alerted healthcare providers and patients about a shortage of tracheostomy tubes, particularly those manufactured by ICU Medical, which affected many pediatric patients due to the limited availability of alternative tubes with similar functionalities.
Market Segmentation
The North American tracheostomy market can be segmented based on type, technique, end user, and country.
1. By Type: The market is divided into tracheostomy tubes, tracheostomy ventilation accessories, other accessories, and tracheostomy cleaning and care kits. In 2023, the tracheostomy tubes segment held the largest market share, reflecting its critical role in the procedure.
2. By Technique: The market is categorized into surgical tracheostomy and percutaneous dilatational tracheostomy. The percutaneous dilatational tracheostomy segment accounted for a larger share in 2023, likely due to its minimally invasive nature and associated benefits.
3. By End User: The market is further segmented into hospitals and surgery centers, ambulatory care centers, home care settings, and research laboratories and academic institutes. The hospitals and surgery centers segment dominated the market in 2023, as these facilities are primary locations for performing tracheostomy procedures.
4. By Country: The North American tracheostomy market is divided into the United States, Canada, and Mexico, with the U.S. holding the largest market share in 2023.
Key Players in the Market
Several companies are leading the North American tracheostomy market, including AdvaCare Pharma USA LLC, Andreas Fahl Medizintechnik-Vertrieb GmbH, Angiplast, Boston Medical Products Inc, Coloplast Corp, Cook Medical Holdings LLC, Fisher & Paykel Healthcare Corp Ltd, Fuji Systems Corporation, ICU Medical Inc, Intersurgical Ltd, Kapitex Healthcare Limited, Medtronic Plc, SunMed Group Holdings LLC (AirLife), Teleflex Inc, Tianjin Medis Medical Device Co. Ltd., Troge Medical GmbH, VBM Medizintechnik GmbH, and Well Lead Medical Co. Ltd. These companies are instrumental in providing a range of products and innovations that support the tracheostomy market.
In conclusion, the North American tracheostomy market is poised for significant growth, driven by an aging population and increasing respiratory health challenges. The market's dynamics are shaped by various factors, including government initiatives, technological advancements, and the strategic positioning of key players.
As individuals age, they often experience a decline in lung function and an increased risk of respiratory ailments such as chronic obstructive pulmonary disease (COPD), pneumonia, and asthma. The global trend shows a rising geriatric demographic, which is expected to further fuel the demand for tracheostomy interventions. For instance, the U.S. Census Bureau projects that the number of Americans aged 65 and older will increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. This age group is anticipated to grow from 17% to 23% of the total U.S. population by 2050. Similarly, Statistics Canada reported that in 2022, approximately 18.8% of Canadians, or about 7.3 million people, were aged 65 or older. The World Health Organization (WHO) also highlights that by 2030, one in six people globally will be aged 60 or older, with the number expected to reach 1.4 billion by 2030 and 2.1 billion by 2050. Notably, by 2050, 80% of older individuals will reside in low- and middle-income countries. This demographic shift is a key driver for the growth of the tracheostomy market in North America.
A tracheostomy is a surgical procedure that involves creating an opening in the front of the neck to access the trachea directly. This procedure is commonly performed in cases of airway obstruction, respiratory failure, trauma, or when prolonged mechanical ventilation is required. According to a 2020 article in Critical Care Medicine, around 100,000 tracheostomies are performed annually in the United States alone.
The North American tracheostomy market is also influenced by government initiatives aimed at addressing product shortages. For example, in October 2022, the U.S. Food and Drug Administration (FDA) alerted healthcare providers and patients about a shortage of tracheostomy tubes, particularly those manufactured by ICU Medical, which affected many pediatric patients due to the limited availability of alternative tubes with similar functionalities.
Market Segmentation
The North American tracheostomy market can be segmented based on type, technique, end user, and country.
1. By Type: The market is divided into tracheostomy tubes, tracheostomy ventilation accessories, other accessories, and tracheostomy cleaning and care kits. In 2023, the tracheostomy tubes segment held the largest market share, reflecting its critical role in the procedure.
2. By Technique: The market is categorized into surgical tracheostomy and percutaneous dilatational tracheostomy. The percutaneous dilatational tracheostomy segment accounted for a larger share in 2023, likely due to its minimally invasive nature and associated benefits.
3. By End User: The market is further segmented into hospitals and surgery centers, ambulatory care centers, home care settings, and research laboratories and academic institutes. The hospitals and surgery centers segment dominated the market in 2023, as these facilities are primary locations for performing tracheostomy procedures.
4. By Country: The North American tracheostomy market is divided into the United States, Canada, and Mexico, with the U.S. holding the largest market share in 2023.
Key Players in the Market
Several companies are leading the North American tracheostomy market, including AdvaCare Pharma USA LLC, Andreas Fahl Medizintechnik-Vertrieb GmbH, Angiplast, Boston Medical Products Inc, Coloplast Corp, Cook Medical Holdings LLC, Fisher & Paykel Healthcare Corp Ltd, Fuji Systems Corporation, ICU Medical Inc, Intersurgical Ltd, Kapitex Healthcare Limited, Medtronic Plc, SunMed Group Holdings LLC (AirLife), Teleflex Inc, Tianjin Medis Medical Device Co. Ltd., Troge Medical GmbH, VBM Medizintechnik GmbH, and Well Lead Medical Co. Ltd. These companies are instrumental in providing a range of products and innovations that support the tracheostomy market.
In conclusion, the North American tracheostomy market is poised for significant growth, driven by an aging population and increasing respiratory health challenges. The market's dynamics are shaped by various factors, including government initiatives, technological advancements, and the strategic positioning of key players.
Table of Contents
137 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
